Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)
Department of Health and Human Services National Institutes of Health
Type
Research/project funding
Posted on:
Application Deadline:
Expired
Reference Number
PAR-22-185
The purpose of this FOA is to provide a method for investigators to request gap filling preclinical services to academic and private institutions to assist with product development efforts and facilitate the advancement of promising therapeutics for HIV and HIV-associated co-infections (Hepatitis B, Hepatitis C and Tuberculosis).
Categories: Health.
Categories: Health.
United States